| __timestamp | Amneal Pharmaceuticals, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 13774000 |
| Thursday, January 1, 2015 | 109679000 | 22479000 |
| Friday, January 1, 2016 | 118757000 | 27388000 |
| Sunday, January 1, 2017 | 109046000 | 35610000 |
| Monday, January 1, 2018 | 230435000 | 49007000 |
| Tuesday, January 1, 2019 | 289598000 | 61139000 |
| Wednesday, January 1, 2020 | 326727000 | 68836000 |
| Friday, January 1, 2021 | 365504000 | 97592000 |
| Saturday, January 1, 2022 | 399700000 | 106903000 |
| Sunday, January 1, 2023 | 429675000 | 120998000 |
Unleashing insights
In the competitive landscape of pharmaceuticals and biotechnology, managing operational costs is crucial. Amneal Pharmaceuticals, Inc. and Vericel Corporation, two prominent players, have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses from 2014 to 2023. Amneal's SG&A expenses have surged by over 400% during this period, reflecting their aggressive expansion and operational scaling. In contrast, Vericel's expenses have increased by approximately 780%, indicating a strategic push towards growth and market penetration. Notably, Amneal's expenses consistently outpaced Vericel's, peaking at nearly four times higher in 2023. This divergence highlights differing strategic priorities and market dynamics. As these companies navigate the complexities of their industries, understanding their financial strategies offers valuable insights into their future trajectories.
Amgen Inc. vs Vericel Corporation: SG&A Expense Trends
Regeneron Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Biogen Inc. and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
United Therapeutics Corporation vs Vericel Corporation: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and Vericel Corporation
Who Optimizes SG&A Costs Better? Insmed Incorporated or Amneal Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Insmed Incorporated and Vericel Corporation
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.
Cost Management Insights: SG&A Expenses for Vericel Corporation and HUTCHMED (China) Limited